In the context of the current era of rapid development of medical technology, our team is committed to improving the quality of human life through innovative products, especially for individuals suffering from certain genetic diseases. Our main product is an E. coli-based drug. Through advanced DNA synthesis technology, we change the function of E. coli so that it can alleviate the symptoms of patients with phenylketonuria to a certain extent while limiting phenylalanine. intake. After many attempts and optimizations, we decided to provide this drug to customers in the form of milk powder for easier use and acceptance. Our vision is to promote this innovative product globally and help as many children with phenylketonuria as possible relieve their pain so that they can grow up healthily like other normal children. To achieve this goal, we closely integrate entrepreneurship with our product development, aiming to promote the dissemination and application of products through commercialization, thereby contributing to society.
Below is our business plan

Our team conducted in-depth discussions and research before embarking on the business plan. We discussed how to carry out commercial activities comprehensively to ensure that our innovative products can be effectively brought to market and meet the needs of target customers. We developed two business plans and identified the market research plans that needed to be conducted.
This ensures that our products can effectively meet market demand, achieve our commercial goals, and provide effective help for children with phenylketonuria.

Here is our workshop transcript

Here is the first version of our plan

Here is our second version of the plan

Here is our market research content and division of labor

Our team also developed a PowerPoint presentation designed to detail our project, products, and business plan in order to attract the attention and support of potential investors during subsequent pitches. This presentation not only showcases the science, production processes and market potential of our products, it also highlights the strength of our team, core competencies and long-term business vision.
We produced this PPT in the middle of our project, and we will continue to modify it later.
Here is our PPT

We actively conducted in-depth communication and exchanges with the families of children with phenylketonuria, aiming to obtain valuable feedback from their actual needs and experiences. By hearing their comments and suggestions about available treatments, we gained a more comprehensive and practical understanding of treatments for phenylketonuria. This not only deepens our insight into the real needs of patients, but also allows us to optimize our product design and functionality in a targeted manner.

We hope that the profits we make will build a charitable foundation strong enough to attract like-minded people to come together and work toward a common goal. We do our best not only to help PKU patients, but also hope to treat more patients with genetic diseases in the future. So we developed a charitable foundation plan. Please see the Charitable Foundation section of our business plan for details.